23840767|t|Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein.
23840767|a|In prion disease, a profound microglial activation that precedes neurodegeneration has been observed in the CNS. It is still not fully elucidated whether microglial activation has beneficial effects in terms of prion clearance or whether microglial cells have a mainly detrimental function through the release of pro-inflammatory cytokines. To date, no disease-modifying therapy exists. Several immunization attempts have been performed as one therapeutic approach. Recently, naturally occurring autoantibodies against the prion protein (nAbs-PrP) have been detected. These autoantibodies are able to break down fibrils of the most commonly used mutant prion variant PrP106-126 A117V and prevent PrP106-126 A117V-induced toxicity in primary neurons. In this study, we examined the phagocytosis of the prion peptide PrP106-126 A117V by primary microglial cells and the effect of nAbs-PrP on microglia. nAbs-PrP considerably enhanced the uptake of PrP106-126 A117V without inducing an inflammatory response in microglial cells. PrP106-126 A117V uptake was at least partially mediated through scavenger receptors. Phagocytosis of PrP106-126 A117V with nAbs-PrP was inhibited by wortmannin, a potent phosphatidylinositol 3-kinase inhibitor, indicating a separate uptake mechanism for nAbs-PrP mediated phagocytosis. These data suggest the possible mechanisms of action of nAbs-PrP in prion disease. 
23840767	99	112	prion protein	Gene	5621
23840767	117	130	prion disease	Disease	MESH:D017096
23840767	179	196	neurodegeneration	Disease	MESH:D019636
23840767	325	330	prion	Disease	MESH:D017096
23840767	431	453	inflammatory cytokines	Disease	MESH:D000080424
23840767	637	650	prion protein	Gene	5621
23840767	657	660	PrP	Gene	5621
23840767	767	772	prion	Disease	MESH:D017096
23840767	792	797	A117V	ProteinMutation	tmVar:p|SUB|A|117|V;HGVS:p.A117V;VariantGroup:0;CorrespondingGene:5621;RS#:74315402;CorrespondingSpecies:9606;CA#:256776
23840767	821	826	A117V	ProteinMutation	tmVar:p|SUB|A|117|V;HGVS:p.A117V;VariantGroup:0;CorrespondingGene:5621;RS#:74315402;CorrespondingSpecies:9606;CA#:256776
23840767	835	843	toxicity	Disease	MESH:D064420
23840767	940	945	A117V	ProteinMutation	tmVar:p|SUB|A|117|V;HGVS:p.A117V;VariantGroup:0;CorrespondingGene:5621;RS#:74315402;CorrespondingSpecies:9606;CA#:256776
23840767	997	1000	PrP	Gene	5621
23840767	1020	1023	PrP	Gene	5621
23840767	1071	1076	A117V	ProteinMutation	tmVar:p|SUB|A|117|V;HGVS:p.A117V;VariantGroup:0;CorrespondingGene:5621;RS#:74315402;CorrespondingSpecies:9606;CA#:256776
23840767	1097	1109	inflammatory	Disease	MESH:D007249
23840767	1151	1156	A117V	ProteinMutation	tmVar:p|SUB|A|117|V;HGVS:p.A117V;VariantGroup:0;CorrespondingGene:5621;RS#:74315402;CorrespondingSpecies:9606;CA#:256776
23840767	1252	1257	A117V	ProteinMutation	tmVar:p|SUB|A|117|V;HGVS:p.A117V;VariantGroup:0;CorrespondingGene:5621;RS#:74315402;CorrespondingSpecies:9606;CA#:256776
23840767	1268	1271	PrP	Gene	5621
23840767	1289	1299	wortmannin	Chemical	MESH:D000077191
23840767	1310	1339	phosphatidylinositol 3-kinase	Gene	5295
23840767	1399	1402	PrP	Gene	5621
23840767	1487	1490	PrP	Gene	5621
23840767	1494	1507	prion disease	Disease	MESH:D017096
23840767	Association	MESH:D000077191	RS#:74315402;HGVS:p.A117V;CorrespondingGene:5621
23840767	Positive_Correlation	MESH:D064420	RS#:74315402;HGVS:p.A117V;CorrespondingGene:5621
23840767	Negative_Correlation	MESH:D000077191	5295
23840767	Association	5295	5621
23840767	Association	MESH:D000077191	5621
23840767	Association	MESH:D017096	5621
23840767	Association	MESH:D064420	5621

